Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Iterum Therapeutics PLC

ITRM
1,2816
-0,0284 (-2,17%)
Ultimo aggiornamento: 15:55:20
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/3/202513:35EDGAR2Form 8-K - Current report
20/2/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202522:49EDGAR2Form 8-K - Current report
07/2/202522:33EDGAR2Form S-3 - Registration statement under Securities Act of..
07/2/202513:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/2/202513:15EDGAR2Form 8-K - Current report
07/2/202513:00GLOBEIterum Therapeutics Reports Fourth Quarter and Full Year..
31/1/202514:00GLOBEIterum Therapeutics to Report Fourth Quarter and Full Year..
11/12/202412:30EDGAR2Form 8-K - Current report
10/12/202413:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/11/202415:15EDGAR2Form 8-K - Current report
21/11/202414:30GLOBEIterum Therapeutics Regains Full Nasdaq Compliance
14/11/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/11/202413:15EDGAR2Form 8-K - Current report
14/11/202413:00GLOBEIterum Therapeutics Reports Third Quarter 2024 Financial..
11/11/202414:00GLOBEIterum Therapeutics to Report Third Quarter 2024 Financial..
01/11/202422:10EDGAR2Form 8-K - Current report
30/10/202411:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/10/202411:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/10/202410:00PRNUSIterum Therapeutics to Host Morning Conference Call on U.S...
25/10/202417:20EDGAR2Form 8-K - Current report
25/10/202417:03GLOBEIterum Therapeutics Receives U.S. FDA Approval of ORLYNVAH™..
15/10/202414:00EDGAR2Form 8-K - Current report
11/10/202422:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
10/10/202414:30GLOBEIterum Therapeutics to Present Data at IDWeek 2024
09/10/202423:00GLOBEIterum Therapeutics to Participate at the 2024 Maxim..
08/10/202415:15EDGAR2Form 8-K - Current report
04/10/202423:20EDGAR2Form 8-K - Current report
30/9/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/9/202413:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/9/202415:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
24/9/202414:59EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/9/202412:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202422:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/9/202413:00GLOBEIterum Therapeutics Provides Update on FDA Advisory..
09/9/202412:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/9/202422:30GLOBEIterum Therapeutics to Present at the 26th Annual H.C...
14/8/202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
14/8/202413:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202413:15EDGAR2Form 8-K - Current report
14/8/202413:00GLOBEIterum Therapeutics Reports Second Quarter 2024 Financial..
09/8/202423:28EDGAR2Form POS AM - Post-Effective amendments for registration..
07/8/202422:30GLOBEIterum Therapeutics to Report Second Quarter 2024 Financial..
06/8/202423:30GLOBEIterum Therapeutics Announces Expiration and Results of..
06/8/202423:25EDGAR2Form 8-K - Current report
02/8/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
02/8/202414:00GLOBEIterum Therapeutics Broadens Patent Estate for Oral..
22/7/202414:30EDGAR2Form 8-K - Current report
22/7/202413:30GLOBEIterum Therapeutics Commences Rights Offering
19/7/202423:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
Apertura: 1,31 Min: 1,27 Max: 1,31
Chiusura: 1,31

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network